I am very pleased to see the PR state that the company will be providing the data on "[t]he direct relationship between cognitive function and reduced brain region atrophy with blarcamesine." This is exactly what I have been looking for, since it will significantly upgrade the MRI results as a strong biomarker for cognition.
Market Data 
Markets 
AI
